Markind, I agree that I do not believe the revenues will be significant, and probably not for another twelve months until Abbott has several quarters of sales in Canada. However, starting to see revenue build up will be an important sign.
good points markkind, however, Damaj did say they would have some, probably small IMO sales in Q2 on the acquisitions, I don't see APRI as a rev generator yet, I see them as having big moves on approvals, partners -with upfront $$$-, guidance, and launches in Canada, Mena, & France. To me theses are significant pps drivers. Revenvue will be next year.
News 
Market Data 
Discover 
